Brinkkoetter PT - Search Results

1

p35, the non-cyclin activator of Cdk5, protects podocytes against apoptosis in vitro and in vivo.

Brinkkoetter PT, Wu JS, Ohse T, Krofft RD, Schermer B, Benzing T, Pippin JW, Shankland SJ. Brinkkoetter PT, et al. Kidney Int. 2010 Apr;77(8):690-9. doi: 10.1038/ki.2009.548. Epub 2010 Feb 3. Kidney Int. 2010. PMID: 20130526 Free article.

2

Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo.

Logar CM, Brinkkoetter PT, Krofft RD, Pippin JW, Shankland SJ. Logar CM, et al. Among authors: brinkkoetter pt. Kidney Int. 2007 Aug;72(4):489-98. doi: 10.1038/sj.ki.5002362. Epub 2007 Jun 6. Kidney Int. 2007. PMID: 17554257 Free article.

3

Establishment of conditionally immortalized mouse glomerular parietal epithelial cells in culture.

Ohse T, Pippin JW, Vaughan MR, Brinkkoetter PT, Krofft RD, Shankland SJ. Ohse T, et al. Among authors: brinkkoetter pt. J Am Soc Nephrol. 2008 Oct;19(10):1879-90. doi: 10.1681/ASN.2007101087. Epub 2008 Jul 2. J Am Soc Nephrol. 2008. PMID: 18596122 Free PMC article.

4

Inducible rodent models of acquired podocyte diseases.

Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, Kowalewska J, Krofft RD, Logar CM, Marshall CB, Ohse T, Shankland SJ. Pippin JW, et al. Among authors: brinkkoetter pt. Am J Physiol Renal Physiol. 2009 Feb;296(2):F213-29. doi: 10.1152/ajprenal.90421.2008. Epub 2008 Sep 10. Am J Physiol Renal Physiol. 2009. PMID: 18784259 Free article. Review.

5

Rosuvastatin protects against podocyte apoptosis in vitro.

Cormack-Aboud FC, Brinkkoetter PT, Pippin JW, Shankland SJ, Durvasula RV. Cormack-Aboud FC, et al. Among authors: brinkkoetter pt. Nephrol Dial Transplant. 2009 Feb;24(2):404-12. doi: 10.1093/ndt/gfn528. Epub 2008 Sep 27. Nephrol Dial Transplant. 2009. PMID: 18820279 Free PMC article.

6

Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells.

Brinkkoetter PT, Olivier P, Wu JS, Henderson S, Krofft RD, Pippin JW, Hockenbery D, Roberts JM, Shankland SJ. Brinkkoetter PT, et al. J Clin Invest. 2009 Oct;119(10):3089-101. doi: 10.1172/JCI37978. Epub 2009 Sep 1. J Clin Invest. 2009. PMID: 19729834 Free PMC article.

7

Novel siRNA delivery system to target podocytes in vivo.

Hauser PV, Pippin JW, Kaiser C, Krofft RD, Brinkkoetter PT, Hudkins KL, Kerjaschki D, Reiser J, Alpers CE, Shankland SJ. Hauser PV, et al. Among authors: brinkkoetter pt. PLoS One. 2010 Mar 1;5(3):e9463. doi: 10.1371/journal.pone.0009463. PLoS One. 2010. PMID: 20209128 Free PMC article.

8

Cyclin I-Cdk5 governs survival in post-mitotic cells.

Brinkkoetter PT, Pippin JW, Shankland SJ. Brinkkoetter PT, et al. Cell Cycle. 2010 May;9(9):1729-31. doi: 10.4161/cc.9.9.11471. Epub 2010 May 10. Cell Cycle. 2010. PMID: 20404535

9

Both cyclin I and p35 are required for maximal survival benefit of cyclin-dependent kinase 5 in kidney podocytes.

Taniguchi Y, Pippin JW, Hagmann H, Krofft RD, Chang AM, Zhang J, Terada Y, Brinkkoetter P, Shankland SJ. Taniguchi Y, et al. Am J Physiol Renal Physiol. 2012 May 1;302(9):F1161-71. doi: 10.1152/ajprenal.00614.2011. Epub 2012 Jan 18. Am J Physiol Renal Physiol. 2012. PMID: 22262481 Free PMC article.

10

Plasma leakage through glomerular basement membrane ruptures triggers the proliferation of parietal epithelial cells and crescent formation in non-inflammatory glomerular injury.

Ryu M, Migliorini A, Miosge N, Gross O, Shankland S, Brinkkoetter PT, Hagmann H, Romagnani P, Liapis H, Anders HJ. Ryu M, et al. Among authors: brinkkoetter pt. J Pathol. 2012 Dec;228(4):482-94. doi: 10.1002/path.4046. Epub 2012 Jul 26. J Pathol. 2012. PMID: 22553158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters